RT Conference Proceedings
T1 Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
A1 Dziadziuszko, R.
A1 Peters, S.
A1 Gadgeel, S. M.
A1 Mathisen, M. S.
A1 Shagan, S. M.
A1 Felip, E.
A1 Morabito, A.
A1 Cheema, P.
A1 Cobo Dols, M.
A1 Andric, Z.
A1 Barrios, C. H.
A1 Yamaguchi, M.
A1 Dansin, E.
A1 Danchaivijitr, P.
A1 Johnson, M.
A1 Novello, S.
A1 Gandara, D. R.
A1 Schleifman, E.
A1 Wang, J.
A1 Mok, T. S. K.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/26996
UL https://hdl.handle.net/10668/26996
LA en
DS RISalud
RD Apr 6, 2025